Dahl Memorial Clinic Clinic/Center Medicare: Medicare Enrolled Practice Location: 350 14th Avenue, Skagway, AK 99840 Phone: 907-983-2255 Fax: 907-983-2793 |
News Archive
For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent across different types of cancer.
Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.
The Wall Street Journal reports that the six Senate Finance Committee negotiators aren't in agreement about subsidies for low-income people to buy insurance.
Novel strategies are on the way for difficult-to-treat and advanced head and neck cancer, the most heterogeneous group of malignancies which are generally associated with poor survival, and encouraging results have been presented at the first ESMO Asia 2015 Congress in Singapore.
› Verified 6 days ago